Author of 1 Presentation
SS 9.4 - Endovascular revascularisation of acute arterial mesenteric ischemia: 3-year experience report from a dedicated intestinal stroke center unit
Abstract
Purpose
To report the 3-year experience of endovascular revascularization of arterial acute mesenteric ischemia (AMI) from a dedicated intestinal stroke center unit (ISCU).
Material and methods
All patients admitted to the ISCU between January 2016 and January 2019 for arterial AMI who underwent endovascular recanalization were retrospectively analyzed. Patients' demographics, clinical and laboratory characteristics at presentation, together with CT scans were reviewed. The type (thrombolysis, angioplasty, stenting, vasodilators) and the outcome of endovascular procedures (technical success or failure, complications) were noted. Care pathways were described focusing on post-procedural treatments (endovascular or open revascularization, intestinal resection). The 3-month mortality rate was noted.
Results
59 patients (35 men [59%], mean 69±12 yr) were included. Endovascular revascularization was technically successful in 55/59 (93%) patients, and 15 (25%) patients had post-procedural complications. Following this procedure, 33 patients (56%) were alive and recurrence free without further treatment, while 7 (12%), 4 (7%) and 6 (10%) patients underwent 2nd line endovascular revascularization, open revascularization, and resection, respectively. Seven patients (12%) underwent more than one 2nd line treatment. Overall, 48 patients (81%) were alive and recurrence free (mortality rate: 19%).
Conclusion
Endovascular revascularization is highly feasible for the treatment of arterial AMI, and is associated with an acceptable rate of complications. These results can only be interpreted in the context of an integrated multidisciplinary and dedicated management of patients that limits the need for bowel resection, and leads to good survival rates.
Video-on-demand
Presenter of 1 Presentation
SS 9.4 - Endovascular revascularisation of acute arterial mesenteric ischemia: 3-year experience report from a dedicated intestinal stroke center unit
Abstract
Purpose
To report the 3-year experience of endovascular revascularization of arterial acute mesenteric ischemia (AMI) from a dedicated intestinal stroke center unit (ISCU).
Material and methods
All patients admitted to the ISCU between January 2016 and January 2019 for arterial AMI who underwent endovascular recanalization were retrospectively analyzed. Patients' demographics, clinical and laboratory characteristics at presentation, together with CT scans were reviewed. The type (thrombolysis, angioplasty, stenting, vasodilators) and the outcome of endovascular procedures (technical success or failure, complications) were noted. Care pathways were described focusing on post-procedural treatments (endovascular or open revascularization, intestinal resection). The 3-month mortality rate was noted.
Results
59 patients (35 men [59%], mean 69±12 yr) were included. Endovascular revascularization was technically successful in 55/59 (93%) patients, and 15 (25%) patients had post-procedural complications. Following this procedure, 33 patients (56%) were alive and recurrence free without further treatment, while 7 (12%), 4 (7%) and 6 (10%) patients underwent 2nd line endovascular revascularization, open revascularization, and resection, respectively. Seven patients (12%) underwent more than one 2nd line treatment. Overall, 48 patients (81%) were alive and recurrence free (mortality rate: 19%).
Conclusion
Endovascular revascularization is highly feasible for the treatment of arterial AMI, and is associated with an acceptable rate of complications. These results can only be interpreted in the context of an integrated multidisciplinary and dedicated management of patients that limits the need for bowel resection, and leads to good survival rates.
Video-on-demand
Author of 1 Presentation
SS 9.4 - Endovascular revascularisation of acute arterial mesenteric ischemia: 3-year experience report from a dedicated intestinal stroke center unit (ID 519)
Abstract
Purpose
To report the 3-year experience of endovascular revascularization of arterial acute mesenteric ischemia (AMI) from a dedicated intestinal stroke center unit (ISCU).
Material and methods
All patients admitted to the ISCU between January 2016 and January 2019 for arterial AMI who underwent endovascular recanalization were retrospectively analyzed. Patients' demographics, clinical and laboratory characteristics at presentation, together with CT scans were reviewed. The type (thrombolysis, angioplasty, stenting, vasodilators) and the outcome of endovascular procedures (technical success or failure, complications) were noted. Care pathways were described focusing on post-procedural treatments (endovascular or open revascularization, intestinal resection). The 3-month mortality rate was noted.
Results
59 patients (35 men [59%], mean 69±12 yr) were included. Endovascular revascularization was technically successful in 55/59 (93%) patients, and 15 (25%) patients had post-procedural complications. Following this procedure, 33 patients (56%) were alive and recurrence free without further treatment, while 7 (12%), 4 (7%) and 6 (10%) patients underwent 2nd line endovascular revascularization, open revascularization, and resection, respectively. Seven patients (12%) underwent more than one 2nd line treatment. Overall, 48 patients (81%) were alive and recurrence free (mortality rate: 19%).
Conclusion
Endovascular revascularization is highly feasible for the treatment of arterial AMI, and is associated with an acceptable rate of complications. These results can only be interpreted in the context of an integrated multidisciplinary and dedicated management of patients that limits the need for bowel resection, and leads to good survival rates.
Video-on-demand
Presenter of 1 Presentation
SS 9.4 - Endovascular revascularisation of acute arterial mesenteric ischemia: 3-year experience report from a dedicated intestinal stroke center unit (ID 519)
Abstract
Purpose
To report the 3-year experience of endovascular revascularization of arterial acute mesenteric ischemia (AMI) from a dedicated intestinal stroke center unit (ISCU).
Material and methods
All patients admitted to the ISCU between January 2016 and January 2019 for arterial AMI who underwent endovascular recanalization were retrospectively analyzed. Patients' demographics, clinical and laboratory characteristics at presentation, together with CT scans were reviewed. The type (thrombolysis, angioplasty, stenting, vasodilators) and the outcome of endovascular procedures (technical success or failure, complications) were noted. Care pathways were described focusing on post-procedural treatments (endovascular or open revascularization, intestinal resection). The 3-month mortality rate was noted.
Results
59 patients (35 men [59%], mean 69±12 yr) were included. Endovascular revascularization was technically successful in 55/59 (93%) patients, and 15 (25%) patients had post-procedural complications. Following this procedure, 33 patients (56%) were alive and recurrence free without further treatment, while 7 (12%), 4 (7%) and 6 (10%) patients underwent 2nd line endovascular revascularization, open revascularization, and resection, respectively. Seven patients (12%) underwent more than one 2nd line treatment. Overall, 48 patients (81%) were alive and recurrence free (mortality rate: 19%).
Conclusion
Endovascular revascularization is highly feasible for the treatment of arterial AMI, and is associated with an acceptable rate of complications. These results can only be interpreted in the context of an integrated multidisciplinary and dedicated management of patients that limits the need for bowel resection, and leads to good survival rates.